The long-held dominance of Novo Nordisk (NYSE: NVO) in the global obesity market has been dealt a staggering blow following the release of the "worst-case scenario" results from the REDEFINE 4 Phase 3 trial. For years, the Danish pharmaceutical giant was the undisputed leader of the GLP-1 revolution, but the
SAN DIEGO — In a move that sent shockwaves through the semiconductor sector on Tuesday, March 10, 2026, Bank of America Securities officially reinstated its coverage of Qualcomm Incorporated (NASDAQ: QCOM) with a stark "Underperform" rating. The firm set a price target of $145, a significant downward revision from previous estimates,
Shares of Vertex Pharmaceuticals (Nasdaq: VRTX) climbed more than 8% today, reaching a record high as the biotechnology giant unveiled spectacular interim results from its pivotal Phase 3 RAINIER trial. The data, which focused on povetacicept for the treatment of IgA nephropathy (IgAN), showcased a 52% reduction in proteinuria, a
WASHINGTON D.C. — In a decision that has sent shockwaves through the global trade landscape and ignited a firestorm of activity on Wall Street, the Supreme Court of the United States ruled 6-3 in Learning Resources Inc. v. Trump (Case No. 24-1287) that the executive branch overstepped its constitutional authority
As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise. Driven by a historic surge in private equity confidence—now sitting at a six-year high of 86%—the deal-making
NEW YORK — U.S. equity markets witnessed a stunning reversal on Tuesday, March 10, 2026, as investors pivoted from geopolitical panic to a full-throttle "relief rally." The catalyst for the turnaround was a series of afternoon comments from President Donald Trump, who suggested that the intensifying conflict with Iran could
XRP (CRYPTO: XRP) is trading higher Tuesday afternoon as investors react to a fresh ETF catalyst, bullish institutional commentary and an improved risk backdrop across
Veeva Systems shares fell after the company agreed to acquire Ostro for about $100 million to expand its AI-powered, compliant healthcare engagement tools.
Oracle earnings call is highly anticipated and could have a significant impact on the stock price.Answer: Prediction markets are pricing a 77% chance of Oracle beating EPS, but the stock could still drop. Traders are also predicting specific words that will be used and the debt and backlog are concerns. The call will reveal how Oracle competes in the market.
